217 related articles for article (PubMed ID: 26151765)
21. Valproic Acid Induces the Hyperacetylation of P53, Expression of P53 Target Genes, and Markers of the Intrinsic Apoptotic Pathway in Midorganogenesis Murine Limbs.
Paradis FH; Hales BF
Birth Defects Res B Dev Reprod Toxicol; 2015 Oct; 104(5):177-83. PubMed ID: 26305274
[TBL] [Abstract][Full Text] [Related]
22. Valproic acid mediates the synaptic excitatory/inhibitory balance through astrocytes--a preliminary study.
Wang CC; Chen PS; Hsu CW; Wu SJ; Lin CT; Gean PW
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):111-20. PubMed ID: 22343008
[TBL] [Abstract][Full Text] [Related]
23. Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice.
Shen HY; Kalda A; Yu L; Ferrara J; Zhu J; Chen JF
Neuroscience; 2008 Dec; 157(3):644-55. PubMed ID: 18848971
[TBL] [Abstract][Full Text] [Related]
24. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells.
Castro LM; Gallant M; Niles LP
J Neurochem; 2005 Dec; 95(5):1227-36. PubMed ID: 16313512
[TBL] [Abstract][Full Text] [Related]
25. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
[TBL] [Abstract][Full Text] [Related]
26. Valproate-Induced Epigenetic Upregulation of Hypothalamic Fto Expression Potentially Linked with Weight Gain.
Zhang H; Lu P; Tang HL; Yan HJ; Jiang W; Shi H; Chen SY; Gao MM; Zeng XD; Long YS
Cell Mol Neurobiol; 2021 Aug; 41(6):1257-1269. PubMed ID: 32500354
[TBL] [Abstract][Full Text] [Related]
27. Valproic acid inhibits neurosphere formation by adult subventricular cells by a lithium-sensitive mechanism.
Zhou Q; Dalgard CL; Wynder C; Doughty ML
Neurosci Lett; 2011 Aug; 500(3):202-6. PubMed ID: 21741439
[TBL] [Abstract][Full Text] [Related]
28. The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells.
Groh T; Hrabeta J; Khalil MA; Doktorova H; Eckschlager T; Stiborova M
Int J Oncol; 2015 Jul; 47(1):343-52. PubMed ID: 25963435
[TBL] [Abstract][Full Text] [Related]
29. Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition.
Michaelis M; Suhan T; Reinisch A; Reisenauer A; Fleckenstein C; Eikel D; Gümbel H; Doerr HW; Nau H; Cinatl J
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3451-7. PubMed ID: 16123451
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line.
Farrelly LA; Savage NT; O'Callaghan C; Toulouse A; Yilmazer-Hanke DM
Regul Pept; 2013 Sep; 186():123-30. PubMed ID: 23994577
[TBL] [Abstract][Full Text] [Related]
31. Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons.
Kanai H; Sawa A; Chen RW; Leeds P; Chuang DM
Pharmacogenomics J; 2004; 4(5):336-44. PubMed ID: 15289798
[TBL] [Abstract][Full Text] [Related]
32. The antiepileptic and anticancer agent, valproic acid, induces P-glycoprotein in human tumour cell lines and in rat liver.
Eyal S; Lamb JG; Smith-Yockman M; Yagen B; Fibach E; Altschuler Y; White HS; Bialer M
Br J Pharmacol; 2006 Oct; 149(3):250-60. PubMed ID: 16894351
[TBL] [Abstract][Full Text] [Related]
33. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
[TBL] [Abstract][Full Text] [Related]
34. Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock.
Gonzales ER; Chen H; Munuve RM; Mehrani T; Nadel A; Koustova E
J Trauma; 2008 Sep; 65(3):554-65. PubMed ID: 18784568
[TBL] [Abstract][Full Text] [Related]
35. Valproate promotes survival of retinal ganglion cells in a rat model of optic nerve crush.
Zhang ZZ; Gong YY; Shi YH; Zhang W; Qin XH; Wu XW
Neuroscience; 2012 Nov; 224():282-93. PubMed ID: 22867974
[TBL] [Abstract][Full Text] [Related]
36. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes.
Chen PS; Peng GS; Li G; Yang S; Wu X; Wang CC; Wilson B; Lu RB; Gean PW; Chuang DM; Hong JS
Mol Psychiatry; 2006 Dec; 11(12):1116-25. PubMed ID: 16969367
[TBL] [Abstract][Full Text] [Related]
37. Increased human cytomegalovirus replication in fibroblasts after treatment with therapeutical plasma concentrations of valproic acid.
Michaelis M; Köhler N; Reinisch A; Eikel D; Gravemann U; Doerr HW; Nau H; Cinatl J
Biochem Pharmacol; 2004 Aug; 68(3):531-8. PubMed ID: 15242819
[TBL] [Abstract][Full Text] [Related]
38. Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients.
Tremolizzo L; Difrancesco JC; Rodriguez-Menendez V; Riva C; Conti E; Galimberti G; Ruffmann C; Ferrarese C
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):47-51. PubMed ID: 22584634
[TBL] [Abstract][Full Text] [Related]
39. Pentyl-4-yn-VPA, a histone deacetylase inhibitor, ameliorates deficits in social behavior and cognition in a rodent model of autism spectrum disorders.
Foley AG; Cassidy AW; Regan CM
Eur J Pharmacol; 2014 Mar; 727():80-6. PubMed ID: 24486700
[TBL] [Abstract][Full Text] [Related]
40. Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism.
Takuma K; Hara Y; Kataoka S; Kawanai T; Maeda Y; Watanabe R; Takano E; Hayata-Takano A; Hashimoto H; Ago Y; Matsuda T
Pharmacol Biochem Behav; 2014 Nov; 126():43-9. PubMed ID: 25240644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
